Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alan Meds vs Modern Age

Alan Meds
Graded #98

Higher grade

vs+12.399999999999991
Modern Age
Graded #362

Lower grade

The verdict

Alan Meds takes it — 71.1/100 to 58.7/100.

Alan Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering compounded semaglutide and tirzepatide with multiple administration formats including microdosing and oral options.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlan Meds +27
72
45
Dose & formulationAlan Meds +22
75
53
Clinical oversightModern Age +1
82
83
Labs & monitoringModern Age +24
53
77
FulfillmentAlan Meds +19
78
59
Contract termsAlan Meds +35
55
20
Alan Meds · left barModern Age · right bar

The numbers

MetricAlan MedsModern Age
WeighScore71.1/10058.7/100
GradeCC
Scorecard rank#98#362
Semaglutide$158/mo (compounded)Not disclosed
Tirzepatide$295/mo (compounded)Not disclosed
Coverage46 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Alan Meds

Graded #98 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Where it loses points

  • Limited public information on program details
Modern Age

Graded #362 · C

Strengths

  • Uses FDA-approved branded GLP-1 medication (Wegovy/Ozempic), no compounding
  • Comprehensive assessment with labs, at-home tests and clinician review
  • Board-certified clinicians and structured 6-month program
  • Longevity-oriented, whole-person approach beyond weight loss

Where it loses points

  • Expensive: $500 assessment plus $500 program, with medication billed separately
  • Branded GLP-1 can cost $900-1600/mo if not covered by insurance
  • Only available in 16 states (specific states not listed publicly)
  • Premium positioning makes it costlier than compounded-subscription rivals

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard